Evidence map›Paper›PMID 40309444›Full record

ArticleFrontiers in endocrinology2025

NSAID use may decrease serum Klotho levels.

Jingchao Yan, Hong Sun, Xiu Xin, Taomin Huang

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jingchao YanDepartment of Pharmacy, Eye & ENT Hospital, Fudan University, Shanghai, China.
Hong SunDepartment of Pharmacy, Eye & ENT Hospital, Fudan University, Shanghai, China.
Xiu XinDepartment of Pharmacy, Eye & ENT Hospital, Fudan University, Shanghai, China.
Taomin HuangDepartment of Pharmacy, Eye & ENT Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To validate the hypothesis proposed by previous studies, which suggests that NSAID use may elevate Klotho levels. Method: We conducted a cross-sectional study involving 11,626 adults from the National Health and Nutrition Examination Survey (NHANES) 2007-2016. Multivariable linear regression and propensity score analysis were employed to evaluate the association between NSAID use and serum Klotho levels. Additionally, subgroup analyses were performed to assess the consistency of this relationship across various subgroups. Results: Multivariable linear regression analysis demonstrated that NSAID use was negatively correlated with serum Klotho levels (β = -25.48 [95% CI: -42.00, -8.96], p = 0.003). Additionally, sensitivity analysis results were consistent with the primary analysis. Subgroup analyses did not reveal any statistically significant interactions. Conclusion: Contrary to previous speculations, the use of NSAIDs is associated with a decrease in serum Klotho levels.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalBiomarkersGlucuronidaseAdultAgedCross-Sectional StudiesFemaleHumansKlotho ProteinsMaleMiddle AgedNutrition SurveysAnti-Inflammatory Agents, Non-SteroidalBiomarkersGlucuronidaseKlotho ProteinsKL protein, humanagingcyclooxygenaseinflammationNSAIDsα-Klotho (Klotho)

Identifiers

PMID40309444
PMCPMC12040623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.